Sector Chart Ribomic Inc.

Stocks

4591

JP3974850004

Biotechnology & Medical Research

Delayed Japan Exchange 05:41:40 05/10/2026 +04			5-day change	1st Jan Change
75.00 ^JPY	-1.32%		-2.60%	-3.85%

08-24	Ribomic Announces Completion of Clinical Trial Site Establishment for the Phase 3 Clinical Trial of Umedaptanib Pegol in Achondroplasia	CI
08-13	Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes